| Companies sponsors |
Almirall (lebrikizumab) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Eczema Outreach Support |
| |
National Eczema Society |
| Professional groups |
British Association of Dermatologists |
| |
Royal College of Physicians |
| Comparator companies |
AbbVie (upadacitinib) (confidentiality agreement signed, participating) |
| |
Accord (azathioprine, methotrexate, mycophenolate mofetil) (confidentiality agreement not signed, not participating) |
| |
Advanz Pharma (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Aspen (azathioprine) (confidentiality agreement not signed, not participating) |
| |
Cipla (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Dexcel-Pharma Limited (ciclosporin) (confidentiality agreement not signed, not participating) |
| |
Eli Lilly (baricitinib) (confidentiality agreement signed, participating) |
| |
Ennogen (azathioprine) (confidentiality agreement not signed, not participating) |
| |
Hospira (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Leo Pharma (tralokinumab) (confidentiality agreement not signed, not participating) |
| |
Medac (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Morningside Healthcare (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Mylan (azathioprine, ciclosporin, mycophenolate mofetil) (confidentiality agreement not signed, not participating) |
| |
Nordic Pharma (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Novartis Pharmaceuticals (ciclosporin, mycophenolate mofetil) (confidentiality agreement not signed, not participating) |
| |
Orion Pharma (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Pfizer (abrocitinib, methotrexate) (confidentiality agreement not signed, not participating) |
| |
Roche (mycophenolate mofetil) (confidentiality agreement not signed, not participating) |
| |
Rosemont Pharmaceuticals (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Sandoz (methotrexate, mycophenolate mofetil) (confidentiality agreement not signed, not participating) |
| |
Sanofi (dupilumab) (confidentiality agreement signed, participating) |
| |
Strides Pharma (azathioprine) (confidentiality agreement not signed, not participating) |
| |
Teva (mycophenolate mofetil) (confidentiality agreement not signed, not participating) |
| |
Therakind (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Tilomed Laboratories (azathioprine, mycophenolate mofetil) (confidentiality agreement not signed, not participating) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health, Social Services and Public Safety for Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |